Boonstra, Heather.
Mifepristone in the United States: Status and Future. / Heather Boonstra. - Guttmacher Report on Public Policy, 2002. - SIRS Enduring Issues 2003. Article 76. Human Relations, 1522-3248; .
Articles Contained in SIRS Enduring Issues 2003. Originally Published: Mifepristone in the United States: Status and Future, Aug. 2002; pp. 4-7.
"Less than two years after the Food and Drug Administration approved the use of mifepristone for early nonsurgical abortion, a majority of the specialized clinics that provide surgical abortion in the United States are now offering it. But while many abortion rights supporters had hoped that the drug's approval also would lead substantial numbers of new providers, particularly physicians in private practice, to take up medical abortion, for a number of reasons this has yet to occur." (GUTTMACHER REPORT ON PUBLIC POLICY) The author hypothesizes "that the introduction of mifepristone in the United States will not noticeably increase the country's abortion rate but, instead, may well increase the proportion of abortions taking place very early in pregnancy.".
1522-3248;
Abortion.
Abortion services.
Birth control.
Mifepristone.
AC1.S5
050
Mifepristone in the United States: Status and Future. / Heather Boonstra. - Guttmacher Report on Public Policy, 2002. - SIRS Enduring Issues 2003. Article 76. Human Relations, 1522-3248; .
Articles Contained in SIRS Enduring Issues 2003. Originally Published: Mifepristone in the United States: Status and Future, Aug. 2002; pp. 4-7.
"Less than two years after the Food and Drug Administration approved the use of mifepristone for early nonsurgical abortion, a majority of the specialized clinics that provide surgical abortion in the United States are now offering it. But while many abortion rights supporters had hoped that the drug's approval also would lead substantial numbers of new providers, particularly physicians in private practice, to take up medical abortion, for a number of reasons this has yet to occur." (GUTTMACHER REPORT ON PUBLIC POLICY) The author hypothesizes "that the introduction of mifepristone in the United States will not noticeably increase the country's abortion rate but, instead, may well increase the proportion of abortions taking place very early in pregnancy.".
1522-3248;
Abortion.
Abortion services.
Birth control.
Mifepristone.
AC1.S5
050